Aspapure Pharma Llp - Company Profile

It is a chemicals limited liability partnership based in Mumbai, Maharashtra, India, established in 2019.
2019 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Aspapure Pharma Llp

Aspapure Pharma Llp, a active limited liability partnership, was established on 18 December 2019 in Mumbai, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds LLPIN: AAR-3460. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Prashant Prabhakar Kotkar (Designated Partner), Sonali Prashant Kotkar (Designated Partner). It holds ₹7.50 M open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at Plot No 58/59, Shop No. 1, Sector 9, Diwa, Mumbai, Maharashtra, 400708.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAR-3460

  • Incorporation Date

    18 December 2019

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 6 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.50 M
Company report

Aspapure Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aspapure Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Aspapure Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Prashant Prabhakar Kotkar Designated Partner 18 Dec 2019 Current
Sonali Prashant Kotkar Designated Partner 18 Dec 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aspapure Pharma Llp.

Enhance accessibility to Aspapure Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Aspapure Pharma Llp revenue growth over time
Aspapure Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aspapure Pharma Llp?

Unlock access to Aspapure Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Idbi Bank Limited : 0.75 Cr
Latest Charge Details
Date Lender Amount Status
19 Oct 2022 Idbi Bank Limited ₹7.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Aspapure Pharma Llp?

Unlock and access historical data on people associated with Aspapure Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aspapure Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspapure Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aspapure Pharma Llp
Recent Activity within the Organization
  • Charges

    The activity A charge with Idbi Bank Limited of Rs. 7.50 M registered on 19 Oct 2022 with Charge ID 100667095 was modified on 31 May 2025. was completed.

  • Annual General Meeting

    The activity Aspapure Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Aspapure Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Charges

    A charge with Idbi Bank Limited amounted to Rs. 7.50 M with Charge ID 100667095 was registered on 19 Oct 2022. was recorded as a recent event.

  • Director Appointment

    Prashant Prabhakar Kotkar was appointed as a Designated Partner was appointed as a Designated Partner on 18 Dec 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Sonali Prashant Kotkar was appointed as a Designated Partner was appointed as a Designated Partner on 18 Dec 2019 & has been associated with this company since 6 years 1 month . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Aspapure Pharma Llp?

The LLPIN of Aspapure Pharma Llp is AAR-3460.

Where is Aspapure Pharma Llp headquartered?

Aspapure Pharma Llp is headquartered at Plot No 58/59, Shop No. 1, Sector 9, Diwa, Mumbai, Maharashtra, 400708.

When was Aspapure Pharma Llp incorporated?

Aspapure Pharma Llp was incorporated on 18 December 2019.

Who are the current directors of Aspapure Pharma Llp?

The current directors of Aspapure Pharma Llp are

What is the primary industry of Aspapure Pharma Llp?

The primary industry of Aspapure Pharma Llp is Chemicals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available